From smart receptors to novel biologics, scientists plan to overcome the challenges of treating solid tumors.

Scientists transferred light-harvesting proteins into yeast for the first time, shining a light on the past lives of eukaryotic cells.

Animals with human cells could provide donor organs or help us understand neuropsychiatric disorders.

The common fluorescent marker GFP traveled a long road to take its popular place in molecular biology today.

The high-quality genome sequence sheds light on the colorful nature of these popular aquarium fish.

Bioengineered bacteria sneak past solid tumor defenses to guide CAR T cells’ attacks.

Self-contained synthetic E. coli resistant to viral infection could prove invaluable to the biotechnology industry by increasing product consistency and reducing safety concerns. 

Rewriting the genetic code can lead to a better understanding of how living cells work, and spawn new biotechnological applications.

Life sciences took center stage virtually around the world June 26. President Bill Clinton, flanked on the left by Celera Genomics Group president J. Craig Venter and on the right by National Human Genome Research Institute director Francis S. Collins, announced the completion of "the first survey of the entire human genome."

The Human Genome Project's discovery1 that the human body runs on an instruction manual of a mere 35,000 or so genes--compared to the worm's 19,000, the fruit fly's 13,000, and the tiny mustard relative Arabidopsis thaliana's 25,000--placed humanity on an even playing field with these other, supposedly simpler, organisms. It was a humbling experience, but humility quickly gave way to awe with the realization that the human genome might encode 100,000 to 200,000 proteins. Scientists base this num